Cargando…
Rectal use of levetiracetam: best practice report for a stepwise approach for sustainable off-label decision making and treatment
Off-label drug use is common practice in palliative care. It may pose a risk to the patient and benefit should outweigh harm. A decision and documentation aid for off-label use was developed to support practitioners in clinical practice off-label use. Using the example of the rectal administration o...
Autores principales: | Rémi, Constanze, Hermann, Alina, Krull, Elisabeth, Ockert-Schön, Franziska, Rémi, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250260/ https://www.ncbi.nlm.nih.gov/pubmed/36753020 http://dx.doi.org/10.1007/s11096-023-01539-3 |
Ejemplares similares
-
Levetiracetam Rectal Administration in Healthy Dogs
por: Peters, R.K., et al.
Publicado: (2014) -
Open‐label clinical trial of rectally administered levetiracetam as supplemental treatment in dogs with cluster seizures
por: Cagnotti, Giulia, et al.
Publicado: (2019) -
Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
por: Westphal, Sophia, et al.
Publicado: (2021) -
Multiple drugs: Rectal bleeding and off label use: case report
Publicado: (2021) -
Pharmacokinetics of rectal levetiracetam as add-on treatment in dogs affected by cluster seizures or status epilepticus
por: Cagnotti, Giulia, et al.
Publicado: (2018)